SELLAS Life Sciences (SLS) Return on Capital Employed Growth (3y) (2015 - 2026)
SELLAS Life Sciences (SLS) Return on Capital Employed Growth (3y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
-494.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
SELLAS Life Sciences |
1.39 Bn |
1.39 Bn |
- |
34,863.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
34,863.00 |
| Dec 31, 2025 |
47,840.00 |
| Sep 30, 2025 |
19,175.00 |
| Jun 30, 2025 |
20,194.00 |
| Mar 31, 2025 |
16,440.00 |
| Dec 31, 2024 |
-14,092.00 |
| Sep 30, 2024 |
-27,105.00 |
| Jun 30, 2024 |
-40,962.00 |
| Mar 31, 2024 |
-403,281.00 |
| Dec 31, 2023 |
66,045.00 |
| Sep 30, 2023 |
-228,586.00 |
| Jun 30, 2023 |
-16,782.00 |
| Mar 31, 2023 |
-21,666.00 |
| Dec 31, 2020 |
5,044.00 |
| Sep 30, 2020 |
-15,297.00 |
| Jun 30, 2020 |
-16,172.00 |
| Mar 31, 2020 |
40,765.00 |
| Dec 31, 2017 |
-4,481.00 |
| Sep 30, 2017 |
7,245.00 |
| Jun 30, 2017 |
5,354.00 |
